Adult-onset re-emergent stuttering as a presentation of Parkinson's disease

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 9, 2005, Pages 579-581

  Lim, Erle C H ^a   Wilder Smith, E ^a   Ong, B K C ^a   Seet, R C S ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Parkinson's disease; Re emergent; Stuttering

Indexed keywords

BROMOCRIPTINE;

ADULT; ARTICLE; ASSOCIATION; BASAL GANGLION; BRADYKINESIA; CASE REPORT; DISEASE ASSOCIATION; DRUG RESPONSE; DYSTONIA; GAIT DISORDER; HUMAN; HYPOKINESIA; MALE; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; RIGIDITY; SPEECH; STUTTERING; TREMOR;

EID: 29144502209     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56(Suppl 5):S1-S88.
2. Ludlow CL, Loucks T. Stuttering: a dynamic motor control disorder. J Fluency Disord 2003;28:273-95.
3. Wingate ME. A standard definition of stuttering. J Speech Hear Disord 1964;29:484-9.
4. Bakwin H, Bakwin RM. Disorders of speech. In: Bakwin H, Bakwin RM, editors. Behavior Disorders in Children. Philadelphia: WB Saunders, 1972:401-2.
5. Koller WC. Dysfluency (stuttering) in extrapyramidal disease. Arch Neurol 1983;40:175-7.
6. Maguire GA, Riley GD, Yu BP. A neurological basis of stuttering? Lancet Neurol 2002;1:407.
7. Ludlow CL, Rosenberg J, Fair C, Buck D, Schesselman S, Salazar A. Brain lesions associated with nonfluent aphasia fifteen years following penetrating head injury. Brain 1986;109:55-80.
8. Lebrun Y, Devreux F, Rousseau JJ. Language and speech in a patient with a clinical diagnosis of progressive supranuclear palsy. Brain Lang 1986;27:247-56.
9. Moretti R, Torre P, Antonello RM, Capus L, Gioulis M, Zambito Marsala S, et al. "Speech initiation hesitation" following subthalamic nucleus stimulation in a patient with Parkinson's disease. Eur Neurol 2003;49: 251-3.
10. Sveinbjornsdottir S, Pakkenberg H, Werdelin L. Developmental stuttering followed by intermittent jaw opening dystonia. Mov Disord 1993;8: 396-7.
11. Abwender DA, Trinidad KS, Jones KR, Como PG, Hymes E, Kurlan R. Features resembling Tourette's syndrome in developmental stutterers. Brain Lang 1998;62:455-64.
12. Brin MF, Stewart C, Blitzer A, Diamond B. Laryngeal botulinum toxin injections for disabling stuttering in adults. Neurology 1994;44:2262-6.
13. Mulder LJ, Spierings EL. Stuttering relieved by divalproex sodium. Neurology 2003;61:714.
14. Sandyk R. Speech impairment in Parkinson's disease is improved by transcranial application of electromagnetic fields. Int J Neurosci 1997;92:63-72.
15. Lavid N, Franklin DL, Maguire GA. Management of child and adolescent stuttering with olanzapine: three case reports. Ann Clin Psychiatry 1999;11:233-6.
16. Wu J, Maguire G, Riley G, Lee A, Keator D, Tang C, et al. Increased dopamine activity associated with stuttering. Neuroreport 1997;8: 767-70.
17. Shahed J, Jankovic J. Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis. Mov Disord 2001;16:114-8.
18. Louis ED, Winfield L, Fahn S, Ford B. Speech dysfluency exacerbated by levodopa in Parkinson's disease. Mov Disord 2001;16:562-5.
19. Benke T, Hohenstein C, Poewe W, Butterworth B. Repetitive speech phenomena in Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:319-24.
20. Alm PA. Stuttering and the basal ganglia circuits: a critical review of possible relations. J Comm Disord 2004;37:325-69.